Cargando…

Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology

PURPOSE: MCM7 (minichromosome maintenance complex component 7), a DNA replication licensing factor, is a host gene for the oncogenic miR-106b~25 cluster. It has been recently revealed as a relevant prognostic biomarker in a variety of cancers, including pituitary adenomas. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbicz, Filip, Mehlich, Dawid, Rak, Beata, Sajjad, Emir, Maksymowicz, Maria, Paskal, Wiktor, Zieliński, Grzegorz, Włodarski, Paweł K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508039/ https://www.ncbi.nlm.nih.gov/pubmed/28432562 http://dx.doi.org/10.1007/s11102-017-0805-y

Ejemplares similares

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways
por: Grzywa, Tomasz M., et al.
Publicado: (2019)

Silent Crooke’s cell corticotroph adenoma of the pituitary gland presenting as delayed puberty
por: Giri, Dinesh, et al.
Publicado: (2017)

PMON324 Crooke Cell Corticotroph Adenoma: A rare but Real Possibility in Children
por: Mamilly, Leena, et al.
Publicado: (2022)

Pituitary Crooke Cell Adenoma: Two Cases of an Aggressive Pituitary Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Double pituitary adenomas in a large surgical series
por: Zieliński, Grzegorz, et al.
Publicado: (2019)

Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing’s Disease
por: Rak, Beata, et al.
Publicado: (2021)

Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors
por: Mossakowska, Beata J., et al.
Publicado: (2022)

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease
por: Akirov, Amit, et al.
Publicado: (2021)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre
por: Witek, Przemysław, et al.
Publicado: (2016)

SAT-483 A Rare Case of Pituitary Adenoma: The Mysterious Crooke's Cell Adenoma
por: Padniewski, Jessica, et al.
Publicado: (2019)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Corticotroph adenoma and pituitary fungal infection: a rare association
por: Catarino, Diana, et al.
Publicado: (2020)

Endoscopic endonasal transcavernous approach for invasive corticotroph pituitary adenoma
por: Lan, Ming-Ying, et al.
Publicado: (2020)

Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior
por: Liu, Xiaohai, et al.
Publicado: (2019)

Co Existence of a Corticotroph Adenoma and a Multifunctional Pituitary Cyst
por: McDonnell, David John, et al.
Publicado: (2021)

Refractory corticotroph adenomas
por: Sumal, Amit K. S., et al.
Publicado: (2023)

MON-255 Oral Contraceptive Pills Mask an Aggressive Crooke’s Cell Pituitary Adenoma
por: Gnanapragasam, Helen Prathiba, et al.
Publicado: (2020)

The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment
por: Mossakowska, Beata Joanna, et al.
Publicado: (2022)

Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway
por: Jian, Fangfang, et al.
Publicado: (2016)

Neurocysticercosis, Meningioma, and Silent Corticotroph Pituitary Adenoma in a 61-Year-Old Woman
por: Ramirez, Maria del Pilar, et al.
Publicado: (2012)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature
por: Pecorari, Isabella L., et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
por: Zhu, Dimin, et al.
Publicado: (2022)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

Pituitary Cachexia Treated with Corticotrophic Hormone
por: Hemphill, R. E.
Publicado: (1946)

Sex differences in pituitary corticotroph excitability
por: Duncan, Peter J., et al.
Publicado: (2023)

Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas
por: Sbiera, Silviu, et al.
Publicado: (2016)

Decreased expression of SFRP2 promotes development of the pituitary corticotroph adenoma by upregulating Wnt signaling
por: Ren, Jie, et al.
Publicado: (2018)

SAT-252 A Rare Case of Crooke’s Adenoma
por: Taiwo, Adeyinka, et al.
Publicado: (2020)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide
por: Asimakopoulou, Athina, et al.
Publicado: (2014)

miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—archival samples study
por: Pełka, Kacper, et al.
Publicado: (2020)

SAT618 Uncovering The Role Of O-glcnacylation In Pituitary Adenoma Pathogenesis: Insights From Corticotroph Tumors
por: Massman, Logan J, et al.
Publicado: (2023)

Metalloproteinase 14 (MMP-14) and hsa-miR-410-3p expression in human inflamed dental pulp and odontoblasts
por: Brodzikowska, Aniela, et al.
Publicado: (2019)

Double, Synchronous Pituitary Adenomas Causing Acromegaly and Cushing’s Disease. A Case Report and Review of Literature
por: Zieliński, Grzegorz, et al.
Publicado: (2013)

Differential microRNA Expression in USP8-Mutated and Wild-Type Corticotroph Pituitary Tumors Reflect the Difference in Protein Ubiquitination Processes
por: Bujko, Mateusz, et al.
Publicado: (2021)

PMON106 Persistent Prolactin Levels in a Patient with Pituitary Adenoma
por: Kadakia, Natasha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e68dq0km1n3duik4r0fdtrmkd1